查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1824523

2025年直接面向消费者（DTC）基因检测全球市场报告

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，直接面向消费者 (DTC) 基因检测市场将快速成长，到 2029 年将达到 38.7 亿美元，复合年增长率为 16.0%。预测期内的成长可归因于检测产品的不断扩展、与个人化医疗的整合、与健康保健产业的合作、基因研究的进步、政府支持以及监管。预测期内的主要趋势包括：检测产品和检测小组的扩展、消费者教育计画、法规遵循与监督、基因组数据研究与贡献，以及价格降低和可及性。

未来五年16.0%的成长率预测比我们先前的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。关税上涨可能会增加美国消费者的负担，因为这将推高来自英国和瑞士的SNP微阵列晶片和唾液采集套件的价格，从而加剧个性化健康洞察的自付费用。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税上涨的影响也将更加广泛。

遗传性疾病和病症的日益普及预计将推动未来直接面向消费者 (DTC) 基因检测市场的成长。遗传性疾病是指由人体 DNA 变化（突变）引起的疾病，包括单一基因、多因子和染色体疾病。直接面向消费者的基因检测可以提高人们对各种遗传性疾病的认识，帮助个人制定健康预测，并提供有关其健康、疾病风险和其他特征的个人化资讯。这些资讯支持旨在降低疾病风险的有效健康和生活方式选择。例如，2023 年 4 月，美国医学图书馆 (NLM) 报告称，预计约有 670 万 65 岁及以上的美国将患上老年痴呆症失智症(AD)，这种疾病很大程度上受遗传影响。如果没有预防、延缓或治疗 AD 的医学突破，到 2060 年，这一数字可能会增加到 1,380 万人。因此，遗传疾病和病症的流行正在推动直接面向消费者 (DTC) 基因检测市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场 - 宏观经济情境宏观经济情境包括利率、通货膨胀、地缘政治、贸易战和关税，以及 COVID-19 大流行和復苏对市场的影响。

第五章 全球成长分析与策略分析框架

  • 全球直接面向消费者 (DTC) 基因检测：PESTEL 分析（政治、社会、技术、环境、法律、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球直接面向消费者（DTC）基因检测市场：成长率分析
  • 全球直接面向消费者 (DTC) 基因检测市场表现：规模与成长，2019-2024 年
  • 全球直接面向消费者 (DTC) 基因检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球直接面向消费者 (DTC) 基因检测：总目标市场 (TAM)

第六章 市场细分

  • 全球直接面向消费者 (DTC) 基因检测市场类型、表现及预测（2019-2024 年、2024-2029 年、2034 年）
  • 携带者检测
  • 预测测试
  • 血统和关係测试
  • 营养基因组检测
  • 其他的
  • 全球直接面向消费者 (DTC) 基因检测市场（按样本类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 唾液
  • 尿
  • 血
  • 全球直接面向消费者 (DTC) 基因检测市场（依技术、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 单核苷酸多态性晶片
  • 全基因组序列分析
  • 目标分析
  • 全球直接面向消费者 (DTC) 基因检测市场的经营模式、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 健康规划模型
  • 综合基因组检测模型
  • 体检模型
  • 限制特性检查模式
  • 全球直接面向消费者 (DTC) 基因检测市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 实验室
  • 血库
  • 护理设施
  • 医院
  • 影像中心
  • 居家医疗
  • 化妆品
  • 其他的
  • 全球直接面向消费者 (DTC) 基因检测市场：载体检测细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 体染色体隐性遗传疾病
  • X连锁疾病
  • 全球直接面向消费者 (DTC) 基因检测市场：预测性检测细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 遗传疾病风险评估
  • 成人发病
  • 全球直接面向消费者 (DTC) 基因检测市场：血统和关係检测细分、按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 祖先组成分析
  • DNA匹配关係
  • 全球直接面向消费者 (DTC) 基因检测市场：营养基因体学检测细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 饮食建议
  • 代谢和健身洞察
  • 全球直接面向消费者 (DTC) 基因检测市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 药物基因组学检测
  • 健康特征测试

第七章 区域和国家分析

  • 全球直接面向消费者 (DTC) 基因检测市场：2019-2024 年、2024-2029 年和 2034 年的区域表现和预测
  • 全球直接面向消费者 (DTC) 基因检测市场：国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 直接面向消费者（DTC）基因检测市场：竞争格局
  • 直接面向消费者（DTC）基因检测市场：公司简介
    • 23andMe
    • AncestryDNA
    • MyHeritage
    • FamilyTreeDNA
    • Living DNA

第31章：其他领先和创新企业

  • Vitagene
  • Orig3n
  • DNAfit
  • Helix
  • Color Genomics
  • Circle DNA
  • CRI Genetics
  • MapMyGenome
  • Invitae Corporation
  • TellmeGen
  • Pathway Genomics
  • Genebase Systems
  • EasyDNA
  • Nebula Genomics
  • Dante Labs

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年直接面向消费者 (DTC) 基因检测市场：提供新机会的国家
  • 2029 年直接面向消费者 (DTC) 基因检测市场：细分市场将带来新机会
  • 2029年直接面向消费者（DTC）基因检测：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r26364u

Direct-to-consumer genetic testing involves marketing genetic tests directly to consumers through various media channels such as radio, television, print adverts, and the internet. Customers can purchase these tests through online marketplaces and pharmacies. After acquiring a test kit, clients provide a DNA sample, gaining access to their genetic data without the need for a healthcare professional or health insurance provider. Results are typically accessed via a secure website, app, or a written report.

Direct-to-consumer (DTC) genetic testing encompasses various types, including carrier testing, predictive testing, ancestry and relationship testing, nutrigenomic testing, and other variants. Carrier screening assesses whether a person carries genetic alterations for specific disorders. These tests analyze saliva, urine, and blood samples using technologies such as single nucleotide polymorphism chips, whole genome sequencing, and targeted analysis. DTC genetic testing operates under different business models such as health planning, comprehensive genome tests, medical precision tests, and restricted trait tests. End-users of these tests include laboratories, blood banks, nursing homes, hospitals, imaging centers, home care, cosmetics, and other sectors.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The direct-to-consumer (DTC) genetic testing market research report is one of a series of new reports from The Business Research Company that provides direct-to-consumer (DTC) genetic testing market statistics, including direct-to-consumer (DTC) genetic testing industry global market size, regional shares, competitors with a direct-to-consumer (DTC) genetic testing market share, detailed direct-to-consumer (DTC) genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (DTC) genetic testing industry. This direct-to-consumer (DTC) genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The direct-to-consumer (dtc) genetic testing market size has grown rapidly in recent years. It will grow from $1.84 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to curiosity about ancestry and heritage, health and wellness trends, marketing and consumer education, privacy and control over genetic data, affordability and accessibility.

The direct-to-consumer (dtc) genetic testing market size is expected to see rapid growth in the next few years. It will grow to $3.87 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to expanding test offerings, integration with personalized medicine, collaborations with health and wellness industries, advancements in genetic research, government support and regulations. Major trends in the forecast period include expanding test offerings and panels, educational initiatives for consumers, regulatory compliance and oversight, genomic data research and contributions, price reduction and accessibility.

The forecast of 16.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. consumers by driving up the cost of SNP microarray chips and saliva collection kits sourced from the UK and Switzerland, exacerbating out-of-pocket expenses for personalized health insights. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diseases and disorders with genetic transmission is anticipated to drive the growth of the direct-to-consumer (DTC) genetic testing market in the future. A genetic disorder is defined as an illness resulting from changes (mutations) in a person's DNA, encompassing single-gene, multifactorial, and chromosomal disorders. Direct-to-consumer genetic testing raises awareness of various genetic disorders, aiding individuals in making health predictions and providing personalized information about their health, disease risks, and other traits. This information supports effective health and lifestyle choices aimed at reducing disease risk. For example, in April 2023, the National Library of Medicine (NLM), a US-based medical library, reported that approximately 6.7 million Americans aged 65 and older were projected to be living with Alzheimer's dementia (AD) in 2023, a condition significantly influenced by genetics. This figure could rise to 13.8 million by 2060 unless medical breakthroughs are made to prevent, slow, or cure AD. Thus, the growing prevalence of genetically transmitted diseases and disorders is propelling the expansion of the direct-to-consumer (DTC) genetic testing market.

The anticipated expansion of digital health solutions is set to drive the growth of the direct-to-consumer (DTC) genetic testing market in the foreseeable future. Digital health leverages technology to enhance healthcare, improve patient outcomes, streamline processes, and empower individuals in managing their health. DTC genetic testing plays a pivotal role in this digital health growth by actively engaging consumers, integrating genetic data for personalization, facilitating telehealth services, connecting with wearable devices, and advocating for preventive care. An example of this trend is highlighted in a September 2022 report from the American Medical Association, a US-based professional organization. The report reveals a significant increase in the percentage of physicians who perceive digital health tools as beneficial for patient care, rising from 85% in 2016 to 93% in 2022. Furthermore, the average number of digital health tools utilized by physicians has also witnessed a notable growth, increasing from 2.2 in 2016 to 3.8 in 2022. Consequently, the surge in digital health solutions is a driving force behind the growth of the direct-to-consumer (DTC) genetic testing market.

Major players in the direct-to-consumer (DTC) genetic testing market are placing a strategic emphasis on substantial investments in genetic research to maintain their market positions. These investments serve as crucial financial support for genetic testing companies, enabling them to engage in research initiatives, advance technologies, broaden market outreach, ensure regulatory compliance, and foster innovation. As an illustrative example, in November 2022, Redcliffe Labs, an India-based provider of diagnostic services and laboratories, disclosed its intention to allocate an additional $10 million (approximately Rs 81 crore) for the expansion of its genetic and specialized testing portfolio. This financial commitment aims to further enhance the company's capabilities in genetic testing, encompassing areas such as prenatal, oncology, neurology, nephrology, and pharmacogenomics. Notably, Redcliffe Labs has already invested $6 million in the coverage of genetics and specialized testing, emphasizing a forward-looking approach towards next-generation technologies within the diagnostics sector.

Major players in the direct-to-consumer (DTC) genetic testing market are actively engaging in strategic collaborations to fortify their market positions. These strategic partnerships, particularly in the realm of technology-integrated genetic testing, serve to drive innovation, elevate diagnostic capabilities, expand global outreach, ensure adherence to regulatory standards, and propel advancements in personalized medicine. A case in point is the collaboration between Myriad Genetics, a US-based genomic testing company, and Epic Systems, a US-based software company, announced in June 2022. This collaboration focuses on integrating electronic health records (EHR) with genetic testing processes. By seamlessly incorporating Myriad tests into the Epic platform, healthcare providers can efficiently order and review genetic tests, streamlining the overall testing procedure. The integration is designed to improve patient care by delivering crucial genetic insights directly within the electronic health records (EHR) system. Myriad Genetics' strategic emphasis on technology-enabled tools aligns with its growth strategy, with the ultimate goal of enhancing accessibility and efficiency in genetic testing for both patients and clinicians.

In March 2022, LetsGetChecked, a virtual care company based in the United States, specializing in at-home testing, telehealth services, and pharmacy capabilities, successfully acquired Veritas Genetics for an undisclosed sum. This strategic acquisition positions LetsGetChecked to leverage whole-genome sequencing, enabling the initiation of a comprehensive lifecycle of personalized healthcare. The goal is to offer the market an extensive spectrum of health testing and care options. Veritas Genetics, the acquired company, is a biotechnology firm based in the United States, specializing in personal genomics.

Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme

North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the direct-to-consumer (dtc) genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The direct-to-consumer (DTC) genetic testing market includes revenues earned by entities by offering DTC genetic kits and services straight to end-customers, that are used in querying patients' DNA information. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on direct-to-consumer (dtc) genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for direct-to-consumer (dtc) genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The direct-to-consumer (dtc) genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Carrier Testing; Predictive Testing; Ancestry And Relationship Testing; Nutrigenomic Testing; Other Types
  • 2) By Sample: Saliva; Urine; Blood
  • 3) By Technology: Single Nucleotide Polymorphism Chips; Whole Genome Sequencing; Targeted Analysis
  • 4) By Business Model: Health Planning Model; Comprehensive Genome Tests Model; Medical Precision Tests Model; Restricted Trait Tests Mode
  • 5) By End User: Laboratories; Blood Banks; Nursing Homes; Hospitals; Imaging Centers; Home Care; Cosmetics; Other End-User
  • Subsegments:
  • 1) By Carrier Testing: Autosomal Recessive Disorders; X-Linked Disorders
  • 2) By Predictive Testing: Risk Assessment For Genetic Conditions; Adult-Onset Conditions
  • 3) By Ancestry And Relationship Testing: Ancestry Composition Analysis; DNA Matching For Relationships
  • 4) By Nutrigenomic Testing: Dietary Recommendations; Metabolism And Fitness Insights
  • 5) By Other Types: Pharmacogenomic Testing; Health Trait Testing
  • Companies Mentioned: 23andMe; AncestryDNA; MyHeritage; FamilyTreeDNA; Living DNA; Vitagene; Orig3n; DNAfit; Helix; Color Genomics; Circle DNA; CRI Genetics; MapMyGenome; Invitae Corporation; TellmeGen; Pathway Genomics; Genebase Systems; EasyDNA; Nebula Genomics; Dante Labs; Veritas Genetics; Xcode Life; Genomic Express; Genomelink; Genomind; WellnessFX; LetsGetChecked; iGene; Dnadoc; OneOme
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Direct-To-Consumer (DTC) Genetic Testing Market Characteristics

3. Direct-To-Consumer (DTC) Genetic Testing Market Trends And Strategies

4. Direct-To-Consumer (DTC) Genetic Testing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Direct-To-Consumer (DTC) Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Direct-To-Consumer (DTC) Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Direct-To-Consumer (DTC) Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Direct-To-Consumer (DTC) Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Direct-To-Consumer (DTC) Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Direct-To-Consumer (DTC) Genetic Testing Total Addressable Market (TAM)

6. Direct-To-Consumer (DTC) Genetic Testing Market Segmentation

  • 6.1. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carrier Testing
  • Predictive Testing
  • Ancestry And Relationship Testing
  • Nutrigenomic Testing
  • Other Types
  • 6.2. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saliva
  • Urine
  • Blood
  • 6.3. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Nucleotide Polymorphism Chips
  • Whole Genome Sequencing
  • Targeted Analysis
  • 6.4. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Business Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Health Planning Model
  • Comprehensive Genome Tests Model
  • Medical Precision Tests Model
  • Restricted Trait Tests Mode
  • 6.5. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratories
  • Blood Banks
  • Nursing Homes
  • Hospitals
  • Imaging Centers
  • Home Care
  • Cosmetics
  • Other End-User
  • 6.6. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autosomal Recessive Disorders
  • X-Linked Disorders
  • 6.7. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Risk Assessment For Genetic Conditions
  • Adult-Onset Conditions
  • 6.8. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Ancestry And Relationship Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ancestry Composition Analysis
  • DNA Matching For Relationships
  • 6.9. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Nutrigenomic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dietary Recommendations
  • Metabolism And Fitness Insights
  • 6.10. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacogenomic Testing
  • Health Trait Testing

7. Direct-To-Consumer (DTC) Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Direct-To-Consumer (DTC) Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Direct-To-Consumer (DTC) Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market

  • 8.1. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Direct-To-Consumer (DTC) Genetic Testing Market

  • 9.1. China Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 9.2. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Direct-To-Consumer (DTC) Genetic Testing Market

  • 10.1. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Direct-To-Consumer (DTC) Genetic Testing Market

  • 11.1. Japan Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 11.2. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Direct-To-Consumer (DTC) Genetic Testing Market

  • 12.1. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market

  • 13.1. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Direct-To-Consumer (DTC) Genetic Testing Market

  • 14.1. South Korea Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 14.2. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market

  • 15.1. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 15.2. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Direct-To-Consumer (DTC) Genetic Testing Market

  • 16.1. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Direct-To-Consumer (DTC) Genetic Testing Market

  • 17.1. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Direct-To-Consumer (DTC) Genetic Testing Market

  • 18.1. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Direct-To-Consumer (DTC) Genetic Testing Market

  • 19.1. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Direct-To-Consumer (DTC) Genetic Testing Market

  • 20.1. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market

  • 21.1. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 21.2. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Direct-To-Consumer (DTC) Genetic Testing Market

  • 22.1. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Direct-To-Consumer (DTC) Genetic Testing Market

  • 23.1. North America Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 23.2. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Direct-To-Consumer (DTC) Genetic Testing Market

  • 24.1. USA Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 24.2. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Direct-To-Consumer (DTC) Genetic Testing Market

  • 25.1. Canada Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 25.2. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Direct-To-Consumer (DTC) Genetic Testing Market

  • 26.1. South America Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 26.2. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Direct-To-Consumer (DTC) Genetic Testing Market

  • 27.1. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Direct-To-Consumer (DTC) Genetic Testing Market

  • 28.1. Middle East Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 28.2. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Direct-To-Consumer (DTC) Genetic Testing Market

  • 29.1. Africa Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 29.2. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Direct-To-Consumer (DTC) Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Direct-To-Consumer (DTC) Genetic Testing Market Competitive Landscape
  • 30.2. Direct-To-Consumer (DTC) Genetic Testing Market Company Profiles
    • 30.2.1. 23andMe Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AncestryDNA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. MyHeritage Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. FamilyTreeDNA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Living DNA Overview, Products and Services, Strategy and Financial Analysis

31. Direct-To-Consumer (DTC) Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Vitagene
  • 31.2. Orig3n
  • 31.3. DNAfit
  • 31.4. Helix
  • 31.5. Color Genomics
  • 31.6. Circle DNA
  • 31.7. CRI Genetics
  • 31.8. MapMyGenome
  • 31.9. Invitae Corporation
  • 31.10. TellmeGen
  • 31.11. Pathway Genomics
  • 31.12. Genebase Systems
  • 31.13. EasyDNA
  • 31.14. Nebula Genomics
  • 31.15. Dante Labs

32. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Direct-To-Consumer (DTC) Genetic Testing Market

34. Recent Developments In The Direct-To-Consumer (DTC) Genetic Testing Market

35. Direct-To-Consumer (DTC) Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Direct-To-Consumer (DTC) Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Direct-To-Consumer (DTC) Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Direct-To-Consumer (DTC) Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer